BMCM
TMO icon

Bryn Mawr Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Bryn Mawr Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.47M Sell
4,936
-51
-1% -$24.5K 0.11% 145
2026
Q1 		$2.45M Sell
4,987
-62
-1% -$33.6K 0.12% 137
2025
Q4 		$2.93M Sell
5,049
-876
-15% -$495K 0.14% 126
2025
Q3 		$2.87M Sell
5,925
-2,380
-29% -$1.11M 0.14% 128
2025
Q2 		$3.37M Buy
8,305
+158
+2% +$66.1K 0.18% 106
2025
Q1 		$4.05M Sell
8,147
-1,918
-19% -$1.04M 0.24% 95
2024
Q4 		$5.24M Sell
10,065
-1,117
-10% -$614K 0.28% 80
2024
Q3 		$6.92M Sell
11,182
-303
-3% -$179K 0.37% 67
2024
Q2 		$6.35M Sell
11,485
-392
-3% -$225K 0.35% 68
2024
Q1 		$6.9M Buy
11,877
+1,768
+17% +$992K 0.39% 65
2023
Q4 		$5.37M Buy
10,109
+1,243
+14% +$602K 0.33% 78
2023
Q3 		$4.49M Buy
8,866
+812
+10% +$433K 0.29% 78
2023
Q2 		$4.2M Sell
8,054
-492
-6% -$265K 0.39% 66
2023
Q1 		$4.93M Sell
8,546
-151
-2% -$85.1K 0.51% 56
2022
Q4 		$4.79M Buy
8,697
+5,799
+200% +$3.07M 0.52% 55
2022
Q3 		$1.47M Sell
2,898
-2
-0.1% -$1.12K 0.52% 48
2022
Q2 		$1.58M Sell
2,900
-48
-2% -$26.4K 0.52% 49
2022
Q1 		$1.74M Buy
+2,948
New +$1.69M 0.49% 54

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Bryn Mawr Capital Management's TMO Position: Q2 2026 in Review

Bryn Mawr Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 1% in Q2 2026, selling an estimated $24.5K and leaving 4,936 shares worth $2.47M. The position accounts for 0.11% of the portfolio, ranked #145.

Bryn Mawr Capital Management first reported a position in TMO in Q1 2022 and has held it in 18 quarters since. The position peaked at $6.92M in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Bryn Mawr Capital Management held 4,936 shares of Thermo Fisher Scientific worth $2.47M as of Q2 2026.
  • Bryn Mawr Capital Management sold 51 Thermo Fisher Scientific shares in Q2 2026, an estimated $24.5K.
  • Thermo Fisher Scientific made up 0.11% of Bryn Mawr Capital Management's portfolio in Q2 2026, its #145 holding.
  • Bryn Mawr Capital Management first reported a position in Thermo Fisher Scientific in Q1 2022 and has held it in 18 quarters since.
  • Bryn Mawr Capital Management's Thermo Fisher Scientific position peaked at $6.92M in Q3 2024.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Bryn Mawr Capital Management's 13F filing for Q2 2026, filed 3 Aug 2026.